SI
SHOULDER INNOVATIONS, INC.
NYSE · Healthcare · Medical - Specialties · US
$20.13
−1.52%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.46
- Revenue estimate
- $15.4M
Latest reported
- Last report date
- May 13, 2026
- EPS actual
- -$0.41
- EPS estimate
- -$0.44
- Revenue actual
- $16.7M
- Revenue estimate
- $14.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +6.8%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $27
- PT range
- $25 – $28
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 13, 2026 | -$0.44 | -$0.41 | Beat 6.82% | $16.7M |
| Sep 8, 2025 | — | -$166 | — | $11.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026